Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Aug 2026.
- Largest single sale: $2.4M (2,000 shares) of Eli Lilly on Aug 10, 2026. Filing
- Last sale before this period: Aug 28, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Eli Lilly (LLY) | SVP, Finance, & CAO | Nov 9, 2012 | Aug 11, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 10, 2026, Eli Lilly: sold 2,000 shares for $2.4M, under a disclosed plan. 1 filing: 1
- Feb 16, 2026, Eli Lilly: 184 shares vested; 82 shares withheld by the company for taxes. 1 filing: 1
- Feb 9, 2026, Eli Lilly: 584 shares awarded. 1 filing: 1
- Nov 13, 2025, Eli Lilly: sold 1,000 shares for $1.0M, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.